Tipsheet: Focus on Multiple Sclerosis Newswise Mon, 10 Jul 2006 9:29 PM PDT The current issue of the Journal of Rehabilitation Research and Development (JRRD) is dedicated to multiple sclerosis rehabilitation.

JRRD tipsheet: Focus on multiple sclerosis EurekAlert! Mon, 10 Jul 2006 11:58 AM PDT The authors describe how the Multiple Sclerosis (MS) Centers of Excellence use healthcare information technology to care for veterans with MS. The approach is based on a chronic-disease model that was effective for diabetes, asthma, and depression.

First trial to investigate effects of cannabinoids on progression of multiple sclerosis News-Medical-Net Mon, 10 Jul 2006 9:34 PM PDT Clinicians from across the UK have now embarked on the world's first trial to investigate whether cannabis derivatives could play a role in slowing the progression of multiple sclerosis.

Consumer Health UPI Tue, 11 Jul 2006 9:14 AM PDT BALTIMORE, July 11 (UPI) -- Medications that affect the central nervous system can impact cognitive function and fatigue in multiple-sclerosis patients, find U.S. researchers.

Health trust won't pay for cannabis ITV.com Tue, 11 Jul 2006 4:13 AM PDT A pensioner who's crippled with pain due to multiple sclerosis has been told her health trust will not fund a cannabis based drug, even though it's the only medicine which offers her relief, and is available to patients living elsewhere in the country.

Parkinson Studies Find More Apathy than Depression, Experience Needed for Brain Stimulation Senior Journal Tue, 11 Jul 2006 8:52 AM PDT July 11, 2006 – Two studies in current scientific journals look at Parkinson disease, which affects about one of every 100 people over the age of 60, and is the most common neurodegenerative disease after Alzheimer's disease. One study found Parkinson patients – often considered to be at high risk of depression – can be apathetic without being depressed and says apathy my be a core feature of the

European Commission approves revision of therapeutic indication for Rebif PharmaBiz Tue, 11 Jul 2006 0:45 AM PDT Serono reported that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) of Rebif (interferon beta-1a), in order to align it with current medical practice.

Yoga helps disabled kids relax, relate and release Baltimore Sun Tue, 11 Jul 2006 5:35 AM PDT Riley Jackson and Shane Perlow, both 7 and ordinarily full of energy, were lying on their backs and taking deep yoga breaths while little plastic frogs on their bellies steadily rose and fell. Soon, they were wobbling and grinning through "tree pose" and hissing enthusiastically for "cat pose." Riley, who has missing front teeth, gaily sang "London Bridge Is Falling Down" as he wiggled into

Prevention Is Better Than Cure: Fighting Autoimmune Diseases Medical News Today Tue, 11 Jul 2006 4:03 AM PDT Centenary scientist Associate Professor Barbara Fazekas de St. Groth, a leader in inflammatory bowel disease research, has demonstrated for the first time the important role of T cells in the prevention of autoimmune diseases in humans. [click link for full article]

Envisioning a Neuro ICU for Preemies at UCSF
UCSF Today Tue, 11 Jul 2006 8:11 AM PDT
Each year in the United States, approximately 80,000 children are born very prematurely. During the past three decades, medical science has provided these tiny preemies with an increased chance of survival — largely through treatments that ensure their lungs can function optimally.